Prognostic factors for hepatocellular carcinoma recurrence.
about
Development and novel therapeutics in hepatocellular carcinoma: a reviewHepPar1-Positive Circulating Microparticles Are Increased in Subjects with Hepatocellular Carcinoma and Predict Early Recurrence after Liver ResectionThe effects of the location of cancer stem cell marker CD133 on the prognosis of hepatocellular carcinoma patientsUpregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway.Pygopus-2 promotes invasion and metastasis of hepatic carcinoma cell by decreasing E-cadherin expression.A comparison of the risk factors of intrahepatic recurrence, early recurrencen, and multiple recurrences after resection for single nodular hepatocellular carcinoma.A Preoperative Measurement of Serum MicroRNA-125b May Predict the Presence of Microvascular Invasion in Hepatocellular Carcinomas Patients.LIVER TRANSPLANTATION FOR CARCINOMA HEPATOCELLULAR IN SÃO PAULO: 414 CASES BY THE MILAN/BRAZIL CRITERIA.Prognostic value of a novel risk classification of microvascular invasion in patients with hepatocellular carcinoma after resection.miR-4417 Targets Tripartite Motif-Containing 35 (TRIM35) and Regulates Pyruvate Kinase Muscle 2 (PKM2) Phosphorylation to Promote Proliferation and Suppress Apoptosis in Hepatocellular Carcinoma Cells.HCC-Associated Liver Transplantation - Where Are the Limits and What Are the New Regulations?Somatostatin receptors in resected hepatocellular carcinoma: status and correlation with markers of poor prognosis.High expression FUT1 and B3GALT5 is an independent predictor of postoperative recurrence and survival in hepatocellular carcinoma.Metastatic recurrence to a solitary lymph node four years after hepatic lobectomy for primary hepatocellular carcinoma.Predisposing factors for hepatocellular carcinoma recurrence following initial remission after transcatheter arterial chemoembolization.Prognostic value and preoperative predictors of microvascular invasion in solitary hepatocellular carcinoma ≤ 5 cm without macrovascular invasion.Prediction and prophylaxis of hepatocellular carcinoma occurrence and postoperative recurrence in chronic hepatitis B virus-infected subjects.The expression of Survivin and NF-κB associated with prognostically worse clinicopathologic variables in hepatocellular carcinoma.Expression Levels of the Uridine-Cytidine Kinase Like-1 Protein As a Novel Prognostic Factor for Hepatitis C Virus-Associated Hepatocellular Carcinomas.Long non-coding RNA SPRY4-IT1 promotes development of hepatic cellular carcinoma by interacting with ERRα and predicts poor prognosis.Surgical Resection vs. Ablative Therapies Through a Laparoscopic Approach for Hepatocellular Carcinoma: a Comparative Study.Anatomical versus non-anatomical resection for solitary hepatocellular carcinoma without macroscopic vascular invasion: A propensity score matching analysis.Using transient elastography to predict hepatocellular carcinoma recurrence after radiofrequency ablation.Targeting autophagy in chemotherapy-resistant of hepatocellular carcinoma.Efficacy of Stereotactic Body Radiotherapy for Recurrent or Residual Hepatocellular Carcinoma after Transcatheter Arterial Chemoembolization.
P2860
Q26752854-FB4823F9-B50B-46C2-BD2D-64B0FB692CB1Q33755269-7A9186CC-55A4-4C82-8AA6-BB3F102873D2Q33885293-D5A405B2-3505-4CA5-B6AB-8F9541705359Q35781460-78BF6616-B6F6-4FD5-96DB-9CF4E3DB952DQ35793718-FD62351B-43CC-416F-9123-D18F51840FA9Q36056566-3286F629-2D9D-4EFB-B76A-B01DB4442F83Q36870217-348873A5-1FCB-45A0-9878-D28507DC160BQ37579484-AE43D40B-F8E0-43C7-A058-B631312F0540Q37706381-5915AAC3-7DCA-4A42-826A-9864F9C24654Q38708241-33249B2E-51A6-4CAD-BBB5-1080F50DC816Q38976824-734461B1-F2E6-4898-8975-3208B896CD42Q40661336-E1050547-75C4-48B3-A52B-50D77B430B28Q41544461-4F7B3AE9-E804-42C3-A336-B2DDE2CB7E38Q41569014-CFEB9213-3256-4AF1-B677-5A6EA4193E96Q41613592-4B0D86A6-2B23-4FE9-9ADA-D3463C9755A9Q41879293-55E8AF11-FDCA-4265-B15F-2332DBC9B789Q42386335-CE004671-E47C-4140-BD6E-F9E312F316D1Q44408295-E8ED406C-4EB2-4009-BEA8-06C4FEE7D7A4Q45325263-C4F868C9-ECC0-43EE-9BBF-6690E3448297Q47097938-A15EA125-83EB-41C8-97B0-0E08A00CC4C8Q47319836-43C4BA34-98AD-4692-AC30-FC532B5FFBE9Q51793441-567990E9-D387-4F3B-AA90-38B6F0D46FBDQ53675583-4856CCFE-07A7-4140-934B-D454DC3FDD1AQ53696566-DB83ED54-936E-42F6-AA51-2EBB1759487EQ55357598-4263A551-BFA2-416B-B055-A6732A5C840D
P2860
Prognostic factors for hepatocellular carcinoma recurrence.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Prognostic factors for hepatocellular carcinoma recurrence.
@en
type
label
Prognostic factors for hepatocellular carcinoma recurrence.
@en
prefLabel
Prognostic factors for hepatocellular carcinoma recurrence.
@en
P2093
P2860
P50
P356
P1476
Prognostic factors for hepatocellular carcinoma recurrence.
@en
P2093
Antonio Colecchia
Martina Taddia
Matteo Cescon
Ramona Schiumerini
P2860
P304
P356
10.3748/WJG.V20.I20.5935
P407
P577
2014-05-01T00:00:00Z